Palatin Technologies
PTN
#10903
Rank
โ‚ฌ10.56 M
Marketcap
5,93ย โ‚ฌ
Share price
-3.60%
Change (1 day)
-45.97%
Change (1 year)

Operating Margin for Palatin Technologies (PTN)

Operating Margin as of November 2026 (TTM): -63.54%

According to Palatin Technologies's latest financial reports and stock price the company's current Operating Margin is -63.54%. At the end of 2026 the company had an Operating Margin of -63.54%.

Operating Margin history for Palatin Technologies from 2001 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
2026-63.54%
2024-662.26%11.95%
2023-591.55%-76%
2022-2,465.06%-86.16%
2021-17,813.91%-6.28%
2020-19,006.88%-32138.77%
201959.32%60.69%
201836.92%-228.68%
2017-28.69%
2015-140.50%
2013-218,274.12%778.46%
2012-24,847.31%2625.06%
2011-911.81%4532.92%
2010-19.68%-65.86%
2009-57.64%-57.77%
2008-136.51%-31.07%
2007-198.05%32.02%
2006-150.01%80.33%
2005-83.19%-92.75%
2004-1,147.17%-29.99%
2003-1,638.59%-72.11%
2002-5,875.49%894.57%
2001-590.76%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
34.58%-154.42%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
21.11%-133.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
24.66%-138.81%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-1,167.54% 1,737.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
59.29%-193.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-61.01%-3.99%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
15.15%-123.84%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-30,182.40% 47,401.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-11.80%-81.43%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.